HEALIUS LIMITED — Director's Dealing 2024

Aug 29, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Charles Taylor
Date of last notice	17 May 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

hispart.
Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest.	As shown
Date of change	27 August 2024
No. of securities held prior tochange	100,000 Ordinary Shares16,450 Ordinary Shares - Citicorp Nominees Pty Limitedon behalf of CPU Share Plans Pty Ltd for Charles Tayloras beneficial owner16,450 NED Share Rights
Class	Ordinary Shares
Number acquired	16,450
Number disposed	Nil

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation	$25,000 cash equivalent using the volume weighted averageprice of Ordinary Shares over the five business days immediatelyfollowing the Healius Limited Annual General Meeting on 28November 2023, being $1.5197 per security.
No. of securities held afterchange	100,000 Ordinary Shares - Charles Taylor32,900 Ordinary Shares - Citicorp Nominees Pty Limited on behalfof CPU Share Plans Pty Ltd for Charles Taylor as beneficial owner.
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back	Vesting of NED Share Rights issued in respect of FY24 intoOrdinary Shares (restricted) under the NED Share Plan.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Mary Weaver Company Secretary Date: 30 August 2024

• See chapter 19 for defined terms.

Appendix

3Y

Page

2